Skip to main
ALAB

ALAB Stock Forecast & Price Target

ALAB Analyst Ratings

Based on 19 analyst ratings
Buy
Strong Buy 37%
Buy 37%
Hold 26%
Sell 0%
Strong Sell 0%

Bulls say

Astera Labs is positioned well for revenue growth through its varied product categories and customer base. With the expected ramp of its Scorpio X switch and continued demand for its Aries, Taurus, and Leo products, Astera Labs's financials will continue to show strong performance. The company's premium valuation is justified by its technology differentiation and strong gross margins, with a focus on AI infrastructure and growing opportunities in the optical market. However, investors should keep an eye on potential risks, including competition in the retimer space and customer concentration among hyperscalers.

Bears say

Astera Labs is a company with a negative outlook due to potential risks in its major revenue stream, hyperscaler spending. While the company offers innovative solutions for data, network, and memory management in AI-driven platforms and has seen strong growth in its retimers and AEC modules, there is increased competition in the scale up switching and NVLink Fusion markets from established players like Broadcom and Marvell. Additionally, the company's optics capabilities, which have been primarily built through talent acquisitions, may require significant investor communication to generate confidence in its future revenue potential.

ALAB has been analyzed by 19 analysts, with a consensus rating of Buy. 37% of analysts recommend a Strong Buy, 37% recommend Buy, 26% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Astera Labs Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Astera Labs Inc (ALAB) Forecast

Analysts have given ALAB a Buy based on their latest research and market trends.

According to 19 analysts, ALAB has a Buy consensus rating as of Jun 2, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $223.95, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $223.95, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Astera Labs Inc (ALAB)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.